JP6978958B2 - Method for producing fermented milk containing bifidobacteria and lactic acid bacteria - Google Patents

Method for producing fermented milk containing bifidobacteria and lactic acid bacteria Download PDF

Info

Publication number
JP6978958B2
JP6978958B2 JP2018024035A JP2018024035A JP6978958B2 JP 6978958 B2 JP6978958 B2 JP 6978958B2 JP 2018024035 A JP2018024035 A JP 2018024035A JP 2018024035 A JP2018024035 A JP 2018024035A JP 6978958 B2 JP6978958 B2 JP 6978958B2
Authority
JP
Japan
Prior art keywords
fermented milk
bifidobacterium
medium
lactic acid
producing fermented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018024035A
Other languages
Japanese (ja)
Other versions
JP2019136002A (en
Inventor
亮太郎 星
彰久 松井
裕恵 富永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP2018024035A priority Critical patent/JP6978958B2/en
Publication of JP2019136002A publication Critical patent/JP2019136002A/en
Application granted granted Critical
Publication of JP6978958B2 publication Critical patent/JP6978958B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Dairy Products (AREA)

Description

本発明は、ビフィドバクテリウム属細菌および乳酸菌を含有する発酵乳の保存時のビフィドバクテリウム属細菌の生残性を改善することのできる発酵乳の製造方法に関する。 The present invention relates to a method for producing fermented milk capable of improving the survivability of bifidobacteria during storage of fermented milk containing bifidobacteria and lactic acid bacteria.

ビフィドバクテリウム属細菌は、ラクトバチルス属細菌等に代表される乳酸菌と同様に、腸内フローラの改善、便性の改善、腸管機能の改善、感染防御、免疫賦活、ガン予防等種々の効果を有することが明らかにされている。そして、これらの細菌は、腸内環境の改善を通して、ヒトの健康に寄与しているものと考えられている。 Bifidobacterium spp., Like lactic acid bacteria represented by Lactobacillus spp., Have various effects such as improvement of intestinal flora, improvement of feces, improvement of intestinal function, infection protection, immunostimulation, and cancer prevention. It has been clarified that it has. These bacteria are thought to contribute to human health through the improvement of the intestinal environment.

このような効果をビフィドバクテリウム属細菌が発揮するためには、発酵乳等の製品中において、高い生菌数を保持することが求められる。しかしながら、ビフィドバクテリウム属細菌は、一般に、嫌気性細菌であるため、生残性に乏しく、特に酸素存在下では、急速に死滅してしまう。 In order for Bifidobacterium spp. To exert such an effect, it is required to maintain a high viable cell count in products such as fermented milk. However, since bifidobacteria are generally anaerobic bacteria, they have poor survival and die rapidly, especially in the presence of oxygen.

これまでに本出願人は上記のようなビフィドバクテリウム属細菌を使用した発酵乳等の製品におけるビフィドバクテリウム属細菌の生残性を高める目的で、甜茶エッセンス等を発酵乳等の製品に添加することを報告している(特許文献1)。 So far, the applicant has used sweet tea essence and the like for products such as fermented milk for the purpose of enhancing the survival of bifidobacteria in products such as fermented milk using the above-mentioned bifidobacteria. It has been reported that it is added to (Patent Document 1).

しかしながら、この方法で製造される発酵乳において、これに含有されるビフィドバクテリウム属細菌は10℃で21日間保存した場合に生残率は40%程度となる。一般的に、摂取時にビフィドバクテリウム属細菌の生菌数が高い方が好ましいため、保存時にも生菌数が維持されることが望まれている。 However, in the fermented milk produced by this method, the bifidobacteria contained therein have a survival rate of about 40% when stored at 10 ° C. for 21 days. In general, it is preferable that the viable cell count of Bifidobacterium spp. Is high at the time of ingestion, and therefore it is desired that the viable cell count is maintained even at the time of storage.

特許第5654824号Patent No. 5654824

従って、本発明の課題は、ビフィドバクテリウム属細菌を含有する発酵乳の保存時のビフィドバクテリウム属細菌の生残性を改善する技術を提供することである。 Therefore, an object of the present invention is to provide a technique for improving the survivability of bifidobacteria during storage of fermented milk containing bifidobacteria.

本発明者らは、上記課題を解決するために鋭意研究した結果、ビフィドバクテリウム属細菌を含有する発酵乳を製造する際に、ビフィドバクテリウム属細菌と乳酸菌とを別々に所定のpHまで発酵させ、それらを混合して発酵乳とすることにより、発酵乳の保存時のビフィドバクテリウム属細菌の生残性を改善できることを見出し、本発明を完成させた。 As a result of diligent research to solve the above problems, the present inventors separately set a predetermined pH for bifidobacteria and lactic acid bacteria when producing fermented milk containing bifidobacteria. We have found that the survival of bifidobacteria during storage of fermented milk can be improved by fermenting them to fermented milk and mixing them to make fermented milk, and completed the present invention.

すなわち、本発明は乳を主成分とする培地Aにビフィドバクテリウム属細菌を接種し、培養して得られるpH4.3〜4.7の培養液(A)と、
乳を主成分とする培地Bに乳酸菌を接種し、培養して得られるpH4.8〜5.4の培養液(B)とを、
混合することを特徴とする発酵乳の製造方法である。
That is, in the present invention, a culture medium (A) having a pH of 4.3 to 4.7 obtained by inoculating a Bifidobacterium genus bacterium into a medium A containing milk as a main component and culturing it is used.
A culture medium (B) having a pH of 4.8 to 5.4 obtained by inoculating a medium B containing milk as a main component with lactic acid bacteria and culturing the medium B is used.
It is a method for producing fermented milk, which is characterized by mixing.

また、本発明は上記発酵乳の製造方法で製造される発酵乳であって、
10℃で21日間保存した場合のビフィドバクテリウム属細菌の生菌数が1×10個/ml以上であることを特徴とする発酵乳である。
Further, the present invention is a fermented milk produced by the above-mentioned method for producing fermented milk.
The fermented milk is characterized in that the viable number of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 1 × 10 9 cells / ml or more.

本発明の発酵乳の製造方法は、ビフィドバクテリウム属細菌と乳酸菌とを別々に所定のpHまで発酵させ、それらを混合して発酵乳とすることにより、発酵乳の保存時のビフィドバクテリウム属細菌の生残性を改善できる。 In the method for producing fermented milk of the present invention, bifidobacteria and lactic acid bacteria are separately fermented to a predetermined pH and mixed to obtain fermented milk, whereby bifidobacteria at the time of storage of fermented milk are obtained. It can improve the survival of Bifidobacterium.

そのため、本発明の発酵乳の製造方法で製造される発酵乳は、商品が消費されるまで健康の増進に有用なビフィドバクテリウム属細菌の生菌数を高く維持できる。 Therefore, the fermented milk produced by the method for producing fermented milk of the present invention can maintain a high viable count of bifidobacteria, which is useful for promoting health, until the product is consumed.

本発明の発酵乳の製造方法(以下、「本発明製法」という)は、
乳を主成分とする培地Aにビフィドバクテリウム属細菌を接種し、培養して得られるpH4.3〜4.7の培養液(A)と、
乳を主成分とする培地Bに乳酸菌を接種し、培養して得られるpH4.8〜5.4の培養液(B)とを、
混合することを特徴とする方法である。
The method for producing fermented milk of the present invention (hereinafter referred to as "the production method of the present invention") is
Bifidobacterium genus bacteria are inoculated into medium A containing milk as a main component and cultured to obtain a culture medium (A) having a pH of 4.3 to 4.7.
A culture medium (B) having a pH of 4.8 to 5.4 obtained by inoculating a medium B containing milk as a main component with lactic acid bacteria and culturing the medium B is used.
It is a method characterized by mixing.

本発明製法に用いられる培地Aは乳を主成分とする培地である、このような培地としてはビフィドバクテリウム属細菌を培養できるものであれば特に限定されないが、例えば、牛乳、脱脂粉乳溶液、全粉乳溶液、ホエーパウダー溶液から選ばれる一種以上を用いた培地が挙げられる。また、これらの培地には、乳ペプチド、ホエーペプチド等の乳由来のペプチド、甜茶エキス等の植物由来のエキス、酵母エキス等の培養助剤、及び/又はブドウ糖、果糖、オリゴ糖類等の(ビフィズス菌または乳酸菌に資化され得る)糖類を適宜含有させてもよい。 The medium A used in the production method of the present invention is a medium containing milk as a main component, and the medium is not particularly limited as long as it can cultivate Bifidobacterium spp., For example, milk or skim milk powder solution. , A medium using one or more selected from a whole milk powder solution and a whey powder solution. In addition, these media include milk-derived peptides such as milk peptides and whey peptides, plant-derived extracts such as sweet tea extract, culture aids such as yeast extract, and / or glucose, fructose, oligosaccharides and the like (Bifizus). Sugars (which can be assimilated into fungi or lactic acid bacteria) may be appropriately contained.

本発明製法に用いられるビフィドバクテリウム属細菌は、特に限定されず、例えば、ビフィドバクテリウム・ロンガム、ビフィドバクテリウム・モンゴリエンセ、ビフィドバクテリウム・ブレーベ、ビフィドバクテリウム・ビフィダム、ビフィドバクテリウム・シュードカテヌラータム、ビフィドバクテリウム・アニマリス、ビフィドバクテリウム・ラクチス等が挙げられる。これらビフィドバクテリウム属細菌の中でもビフィドバクテリウム・ブレーベ、ビフィドバクテリウム・ビフィダム、ビフィドバクテリウム・シュードカテヌラータム、ビフィドバクテリウム・アニマリス、ビフィドバクテリウム・ラクチスが好ましい。また、これらビフィドバクテリウム属細菌は1種以上を用いることができる。 The bacterium belonging to the genus Bifidobacterium used in the production method of the present invention is not particularly limited, and for example, Bifidobacterium longum, Bifidobacterium mongolianse, Bifidobacterium breve, Bifidobacterium bifidam, and bi. Examples thereof include Fidobacterium pseudocatenuratam, Bifidobacterium animalis, and Bifidobacterium lactis. Among these Bifidobacterium spp., Bifidobacterium breve, Bifidobacterium bifidam, Bifidobacterium pseudocatenuratam, Bifidobacterium animalis, and Bifidobacterium lactis are preferable. In addition, one or more of these bifidobacteria can be used.

本発明製法に用いられるビフィドバクテリウム属細菌として特に好ましいのは、ビフィドバクテリウム・ブレーベ YIT12272(FERM BP−11320、受託日:平成22年2月16日)、ビフィドバクテリウム・ビフィダム YIT10347(FERM BP−10613、受託日:平成17年6月23日)である。これらビフィドバクテリウム属細菌や後記する乳酸菌で寄託番号が記載されているものについては、いずれも独立行政法人製品評価技術基盤機構 特許生物寄託センター(〒292−0818日本国千葉県木更津市かずさ鎌足2丁目5番地8 120号室)に寄託されている。 Particularly preferred as the Bifidobacterium genus bacterium used in the production method of the present invention are Bifidobacterium Breve YIT12272 (FERM BP-11320, Contract date: February 16, 2010), Bifidobacterium Bifidum YIT10347. (FERM BP-10613, Contract date: June 23, 2005). All of these bifidobacteria and lactic acid bacteria described below have a deposit number listed at the National Institute of Technology and Evaluation Patent Organism Deposit Center (Kazusakamatari, Kisarazu City, Chiba Prefecture, Japan 292-0818). It has been deposited at 2-5-8, Room 120).

本発明製法においては、上記した培地Aにビフィドバクテリウム属細菌を接種し、pH4.3〜4.7、好ましくは4.3〜4.5まで培養して培養液(A)を得ればよい。そのため、ビフィドバクテリウム属細菌を培養する条件は特に限定されないが、例えば、ビフィドバクテリウム属細菌を培地Aに対して、0.1〜4質量%(以下、「%」という)量で接種し、これを32〜40℃大気または窒素雰囲気下で撹拌培養する条件等が挙げられる。 In the production method of the present invention, the above-mentioned medium A is inoculated with Bifidobacterium spp. And cultured to pH 4.3 to 4.7, preferably 4.3 to 4.5 to obtain a culture solution (A). Just do it. Therefore, the conditions for culturing the bifidobacteria are not particularly limited, but for example, the amount of the bifidobacteria is 0.1 to 4% by mass (hereinafter referred to as "%") with respect to the medium A. Examples thereof include conditions for inoculating and stirring and culturing the medium in an atmosphere of 32 to 40 ° C. or a nitrogen atmosphere.

なお、上記した培地Aにビフィドバクテリウム属細菌を接種する際には、ビフィドバクテリウム属細菌と共に乳酸菌を接種することが好ましい。培地Aに接種される乳酸菌としては特に限定されず、例えば、ストレプトコッカス・サーモフィルス、ラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリクス、ラクトコッカス・ラクチス、ラクトコッカス・クレモリス等が挙げられる。これら乳酸菌の中でもラクトコッカス・ラクチスが好ましい。本発明製法に用いられる乳酸菌として特に好ましいのはラクトコッカス・ラクチス YIT2027(FERM BP−6224、受託日:平成9年2月10日)である。また、これら乳酸菌は1種以上を用いることができる。乳酸菌を培地Aに接種する場合には、0.001〜0.5%量で接種すればよい。 When inoculating the above-mentioned medium A with a bacterium belonging to the genus Bifidobacterium, it is preferable to inoculate the lactic acid bacterium together with the bacterium belonging to the genus Bifidobacterium. The lactic acid bacterium inoculated into the medium A is not particularly limited, and examples thereof include Streptococcus thermophilus, Lactobacillus delbrucky subspecies bulgaricus, Lactococcus lactis, and Lactococcus cremoris. Among these lactic acid bacteria, Lactococcus lactis is preferable. Lactococcus lactis YIT2027 (FERM BP-6224, contract date: February 10, 1997) is particularly preferable as the lactic acid bacterium used in the production method of the present invention. In addition, one or more of these lactic acid bacteria can be used. When the lactic acid bacterium is inoculated into the medium A, it may be inoculated in an amount of 0.001 to 0.5%.

本発明製法に用いられる培地Bは乳を主成分とする培地である、このような培地としては乳酸菌を培養できるものであれば特に限定されないが、例えば、牛乳、脱脂粉乳溶液、全粉乳溶液、ホエーパウダー溶液から選ばれる一種以上を用いた培地が挙げられる。また、これらの培地には、乳ペプチド、ホエーペプチド等の乳由来のペプチド、甜茶エキス等の植物由来のエキス、酵母エキス等の培養助剤、及び/又はブドウ糖、果糖、オリゴ糖類等の(乳酸菌に資化され得る)糖類を適宜含有させてもよい。 The medium B used in the production method of the present invention is a medium containing milk as a main component, and the medium is not particularly limited as long as it can cultivate lactic acid bacteria, but for example, milk, skim milk powder solution, whole milk powder solution, etc. Examples thereof include a medium using one or more selected from whey powder solutions. In addition, these media include milk-derived peptides such as milk peptides and whey peptides, plant-derived extracts such as sweet tea extract, culture aids such as yeast extract, and / or glucose, fructose, oligosaccharides and the like (lactic acid bacteria). Sugars (which can be assimilated into) may be appropriately contained.

本発明製法に用いられる、培地Bに接種される乳酸菌としては、特に限定されず、例えば、ラクトバチルス・カゼイ、ラクトバチルス・アシドフィルス、ラクトバチルス・プランタルム、ストレプトコッカス・サーモフィルス、ラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリクス、ラクトコッカス・ラクチス、ラクトコッカス・クレモリス等が挙げられる。これら乳酸菌の中でもストレプトコッカス・サーモフィルス、ラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリクス、ラクトコッカス・ラクチス、ラクトコッカス・クレモリスが好ましい。また、これら乳酸菌は1種以上を用いることができる。 The lactic acid bacterium to be inoculated into the medium B used in the production method of the present invention is not particularly limited, and is, for example, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus plantarum, Streptococcus thermophilus, Lactobacillus delbrucky. Examples include Subspecies Bulgalix, Lactococcus lactis, Lactococcus cremoris and the like. Among these lactic acid bacteria, Streptococcus thermophilus, Lactobacillus delbrucky subspecies bulgarix, Lactococcus lactis, and Lactococcus cremoris are preferable. In addition, one or more of these lactic acid bacteria can be used.

本発明製法に用いられる培地Bに接種される乳酸菌として特に好ましいのは、ストレプトコッカス・サーモフィルスYIT2021(FERM BP−7537、受託日:平成8年11月1日)である。 Particularly preferable as the lactic acid bacterium to be inoculated into the medium B used in the production method of the present invention is Streptococcus thermophilus YIT2021 (FERM BP-7537, contract date: November 1, 1996).

本発明製法においては、上記した培地Bに乳酸菌を接種し、pH4.8〜5.4、好ましくは4.9〜5.3まで培養して培養液(B)を得ればよい。そのため、乳酸菌を培養する条件は特に限定されないが、例えば、乳酸菌を培地Bに対して、0.0001〜0.01%量で接種し、これを28〜35℃、大気雰囲気下で静置培養する条件等が挙げられる。 In the production method of the present invention, the above-mentioned medium B may be inoculated with lactic acid bacteria and cultured to a pH of 4.8 to 5.4, preferably 4.9 to 5.3 to obtain a culture solution (B). Therefore, the conditions for culturing lactic acid bacteria are not particularly limited, but for example, lactic acid bacteria are inoculated into medium B in an amount of 0.0001 to 0.01%, and this is statically cultured at 28 to 35 ° C. in an air atmosphere. Conditions to be used are mentioned.

なお、本発明製法においては、上記培地の調製や培養にあたり、培地や培養液の均質化、殺菌等の通常の発酵乳の製造にあたって行われる操作を適宜行ってもよい。 In the production method of the present invention, in preparing and culturing the above-mentioned medium, operations such as homogenization of the medium and the culture medium and sterilization may be appropriately performed in the production of normal fermented milk.

上記のようにして得られる培養液(A)と培養液(B)とを混合することにより発酵乳が得られる。混合後の発酵乳のpHは、特に限定されないが、4.5〜5.2、好ましくは4.6〜5.1である。混合後の発酵乳のpHを上記範囲内に調整するためには、培養液(A)と培養液(B)の混合割合を適宜調整すればよく、必要により、クエン酸、リンゴ酸、酢酸、乳酸等の酸や、重曹、炭酸カリウム等のアルカリを用いてもよい。培養液(A)と培養液(B)の混合割合は、特に限定されないが、例えば、1:9〜8:2とすればよく、好ましくは、2:8〜7:3、より好ましくは3:7〜6:4とすればよい。 Fermented milk is obtained by mixing the culture solution (A) and the culture solution (B) obtained as described above. The pH of the fermented milk after mixing is not particularly limited, but is 4.5 to 5.2, preferably 4.6 to 5.1. In order to adjust the pH of the fermented milk after mixing within the above range, the mixing ratio of the culture solution (A) and the culture solution (B) may be appropriately adjusted, and if necessary, citric acid, malic acid, acetic acid, etc. An acid such as lactic acid or an alkali such as baking soda or potassium carbonate may be used. The mixing ratio of the culture solution (A) and the culture solution (B) is not particularly limited, but may be, for example, 1: 9 to 8: 2, preferably 2: 8 to 7: 3, and more preferably 3. : 7 to 6: 4 may be used.

この発酵乳には、必要により、砂糖(ショ糖)、トレハロース、ブドウ糖、果糖、ガラクトース、プシコース等の糖類、マルチトール、ラクチトール、パラチニット、キシリトール等の糖アルコール類、ヨーグルト、シトラス、バニラ、ミルク等の香料、ペクチン、カルボキシセルロースナトリウム、大豆多糖類、アルギン酸ナトリウム、ウェランガム、スクシノグリカン、ゼラチン等の安定剤、ジェランガム、グアガム、キサンタンガム等の増粘多糖類、アスコルビン酸、ビタミンB群、トコフェロール等のビタミン類、スクラロース、ステビア、アセスルファムカリウム、アスパルテーム等の高甘味度甘味料等、通常の発酵乳に添加される任意成分を含有させてもよい。また、この発酵乳の形態も特に限定されず、乳等省令により定められている発酵乳、乳製品乳酸菌飲料等の飲料や、乳等を主原料とする食品等でよい。 This fermented milk contains, if necessary, sugars (sucrose), trehalose, glucose, fructose, galactose, psicose and other sugars, polysaccharide alcohols such as maltitol, lactitol, palatinit, xylitol, yogurt, citrus, vanilla, milk and the like. Perfume, pectin, sodium carboxycellulose, soybean polysaccharide, sodium alginate, welan gum, succinoglycan, stabilizers such as gelatin, thickening polysaccharides such as gellan gum, guagam, xanthan gum, ascorbic acid, vitamin B group, tocopherol, etc. It may contain arbitrary components added to ordinary fermented milk, such as vitamins, sucralose, stevia, acesulfam potassium, high-sweetness sweeteners such as aspartame, and the like. Further, the form of the fermented milk is not particularly limited, and may be a beverage such as a fermented milk, a dairy product lactic acid bacteria beverage, or a food containing milk as a main raw material, which is specified by an ordinance of the Ministry of Milk, etc.

斯くして得られる本発明の発酵乳は、容器に嫌気充填して、製品とすればよい。この製品は、10℃で21日間保存した場合のビフィドバクテリウム属細菌の生菌数が1×10個/ml以上、好ましくは1.2×10個/ml以上である。また、この製品は保存前のビフィドバクテリウム属細菌の初発の生菌数が1.2×10〜2.3×10個/mlであり、好ましくは1.6×10〜2.3×10個/mlである。また、この製品は10℃で21日間保存した場合のビフィドバクテリウム属細菌の生残率が50%以上、好ましくは60%以上であり、より好ましくは70%以上であり、さらに好ましくは80%以上である。なお、生菌数はTOS培地で測定されるものであり、生残率は実施例に記載の式で求められるものである。 The fermented milk of the present invention thus obtained may be anaerobically filled in a container to obtain a product. The viable cell count of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 1 × 10 9 cells / ml or more, preferably 1.2 × 10 9 cells / ml or more. In addition, the initial viable cell count of Bifidobacterium spp. Before storage is 1.2 × 10 9 to 2.3 × 10 9 cells / ml, preferably 1.6 × 10 9 to 2. .3 × 10 9 pieces / ml. In addition, the survival rate of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 50% or more, preferably 60% or more, more preferably 70% or more, still more preferably 80. % Or more. The viable cell count is measured in the TOS medium, and the survival rate is determined by the formula described in the examples.

本発明の発酵乳はビフィドバクテリウム属細菌を保存時でも多く含有するため、これを摂取することで健康の増進に役立つ。 Since the fermented milk of the present invention contains a large amount of Bifidobacterium spp. Even during storage, ingestion of this is useful for improving health.

以下、本発明を実施例を挙げて詳細に説明するが、本発明はこれら実施例に何ら限定されるものではない。 Hereinafter, the present invention will be described in detail with reference to examples, but the present invention is not limited to these examples.

実 施 例 1
発酵乳の調製:
22%脱脂粉乳水溶液に乳ペプチド(CE90GMM、日本新薬(株)製)および甜茶エキス(YTX−13、(株)ヤクルトマテリアル製)を、それぞれ0.1%および0.2%添加し、溶解させ、120℃で3.5秒間加熱殺菌して培養培地aを調製した。この培地にビフィドバクテリウム・ブレーベ YIT12272のスターター(スターターの生菌数:1.2×10cfu/ml)を2%、ラクトコッカス・ラクチス YIT2027のスターター(スターターの生菌数:1.5×10cfu/ml)を0.01%接種して37℃でpHが4.4(酸度は23)となるまで大気雰囲気下で撹拌培養を行い、培養液(a)を160g得た。
Example 1
Preparation of fermented milk:
Milk peptide (CE90GMM, manufactured by Nippon Shinyaku Co., Ltd.) and sweet tea extract (YTX-13, manufactured by Yakult Materials Co., Ltd.) were added to a 22% skim milk powder aqueous solution at 0.1% and 0.2%, respectively, and dissolved. , The culture medium a was prepared by heat sterilizing at 120 ° C. for 3.5 seconds. 2% of Bifidobacterium Breve YIT12272 starter (live starter count: 1.2 × 10 9 cfu / ml) and Lactococcus lactis YIT2027 starter (live starter count: 1.5) in this medium. × 10 9 cfu / ml) was inoculated at 0.01%, and the mixture was stirred and cultured in an air atmosphere at 37 ° C. until the pH became 4.4 (acidity was 23) to obtain 160 g of the culture solution (a).

一方、全粉乳7%および脱脂粉乳13%の水溶液を、120℃で3.5秒間加熱殺菌して培養培地bを調製した。この培地にストレプトコッカス・サーモフィルス YIT2021のスターター(スターターの生菌数:1.3×10cfu/ml)を0.0001%接種して32℃でpHが5.1(酸度は6.3)となるまで静置培養を行い、培養液(b)436gを得た。 On the other hand, an aqueous solution of 7% whole milk powder and 13% skim milk powder was sterilized by heating at 120 ° C. for 3.5 seconds to prepare a culture medium b. Starter of Streptococcus thermophilus YIT2021 to the medium (viable count of starter: 1.3 × 10 9 cfu / ml ) pH at 0.0001% inoculum to 32 ° C. 5.1 (acidity 6.3) The static culture was carried out until 436 g of the culture solution (b) was obtained.

培養液(a)および培養液(b)の全量を各々15MPaで均質化して混合し、混合液を得た(pH4.8)。この混合液に、砂糖10%、スクラロース0.003%、カルボキシメチルセルロースナトリウム1%、ジェランガム0.06%を含有するシロップ水溶液402gおよびヨーグルト香料2gを混合し、発酵乳1000gを得た。これをガラス製の試験管にブチルゴム栓で密栓して嫌気充填し、本発明製品とした。 The total amounts of the culture solution (a) and the culture solution (b) were homogenized at 15 MPa and mixed to obtain a mixed solution (pH 4.8). This mixed solution was mixed with 402 g of a syrup aqueous solution containing 10% sugar, 0.003% sucralose, 1% sodium carboxymethyl cellulose and 0.06% gellan gum and 2 g of yogurt flavor to obtain 1000 g of fermented milk. This was sealed in a glass test tube with a butyl rubber stopper and anaerobically filled to obtain the product of the present invention.

比 較 例 1
発酵乳の調製:
実施例1と同様の培養培地aにビフィドバクテリウム・ブレーベ YIT12272のスターターを2%、ラクトコッカス・ラクチス YIT2027のスターターを0.01%接種して37℃でpHが4.8(酸度は14)となるまで撹拌培養を行い、培養液(a’)を160g得た。また、実施例1と同様にして培養液(b)436gを得た。
Comparison example 1
Preparation of fermented milk:
The same culture medium a as in Example 1 was inoculated with 2% of the starter of Bifidobacterium Breve YIT12272 and 0.01% of the starter of Lactococcus lactis YIT2027, and the pH was 4.8 at 37 ° C. (acidity was 14). ) Was carried out by stirring to obtain 160 g of the culture solution (a'). Moreover, 436 g of the culture solution (b) was obtained in the same manner as in Example 1.

培養液(a’)および培養液(b)の全量を各々15MPaで均質化して混合し、混合液(pH5.0)を得た。この混合液に、実施例1と同様のシロップ水溶液402gおよびヨーグルト香料2gを混合し、発酵乳1000gを得た。これをガラス製の試験管にブチルゴム栓で密栓して嫌気充填し、比較製品とした。 The total amounts of the culture solution (a') and the culture solution (b) were homogenized at 15 MPa and mixed to obtain a mixed solution (pH 5.0). This mixed solution was mixed with 402 g of the same syrup aqueous solution and 2 g of yogurt flavor as in Example 1 to obtain 1000 g of fermented milk. This was sealed in a glass test tube with a butyl rubber stopper and anaerobically filled to obtain a comparative product.

比 較 例 2
発酵乳の調製:
比較例1と同様にして培養液(a’)を160g得た。また、実施例1と同様にして培養液(b)436gを得た。
Comparison example 2
Preparation of fermented milk:
160 g of the culture solution (a') was obtained in the same manner as in Comparative Example 1. Further, 436 g of the culture solution (b) was obtained in the same manner as in Example 1.

培養液(a’)および培養液(b)の全量を各々15MPaで均質化して混合し(pH5.0)、更に乳酸にてpHを4.8に調整して混合液を得た。この混合液に、実施例1と同様のシロップ水溶液402gおよびヨーグルト香料2gを混合し、発酵乳1000gを得た。これをガラス製の試験管にブチルゴム栓で密栓して嫌気充填し比較製品とした。 The total amounts of the culture solution (a') and the culture solution (b) were homogenized at 15 MPa and mixed (pH 5.0), and the pH was further adjusted to 4.8 with lactic acid to obtain a mixed solution. This mixed solution was mixed with 402 g of the same syrup aqueous solution and 2 g of yogurt flavor as in Example 1 to obtain 1000 g of fermented milk. This was sealed in a glass test tube with a butyl rubber stopper and anaerobically filled to make a comparative product.

試 験 例 1
保存試験:
実施例1の本発明製品および比較例1および比較例2の比較製品の製造時(保存日数0日)および10℃保存時の製品のpH、酸度、生菌数、生残率を測定または算出し、表1に示した。なお、pHおよび酸度については常法に従って測定した。また、生菌数はTOS培地(ヤクルト薬品工業株式会社製)を使用して測定し、保存後のビフィドバクテリウム属細菌の生残率は以下の式で求めた。
Trial example 1
Preservation test:
Measure or calculate the pH, acidity, viable cell count, and survival rate of the product of the present invention of Example 1 and the comparative products of Comparative Example 1 and Comparative Example 2 at the time of manufacture (storage days 0 days) and at 10 ° C. And it is shown in Table 1. The pH and acidity were measured according to a conventional method. The viable cell count was measured using a TOS medium (manufactured by Yakult Pharmaceutical Co., Ltd.), and the survival rate of Bifidobacterium spp. After storage was calculated by the following formula.

[数1]
生残率(%)=保存後の生菌数÷製造時の生菌数×100
[Number 1]
Survival rate (%) = number of viable bacteria after storage ÷ number of viable bacteria at the time of manufacture x 100

また、熟練した3名のパネルにより、実施例1の本発明製品および比較例1および比較例2の比較製品の風味を下記評価基準で評価し、評点をつけ、パネル全員の評点の合計からその平均値を算出した。その結果を表1に示した。 In addition, the flavors of the product of the present invention of Example 1 and the comparative products of Comparative Example 1 and Comparative Example 2 were evaluated by the following evaluation criteria by a panel of three skilled persons, and graded, and the total of the scores of all the panels was used. The average value was calculated. The results are shown in Table 1.

<風味評価基準>
評点 : 内容
0 : 保存0日目との酸味の差がない
1 : 保存0日目との酸味の差がややある
2 : 保存0日目との酸味の差がある
3 : 保存0日目との酸味の差がかなりある
<Flavor evaluation criteria>
Score: Content 0: No difference in acidity from 0th day of storage 1: Slight difference in acidity from 0th day of storage 2: Difference in acidity from 0th day of storage 3: With 0th day of storage There is a considerable difference in the acidity of

Figure 0006978958
Figure 0006978958

実施例1の本発明製品は、ビフィドバクテリウム属細菌をpH4.4まで培養した培養液と、乳酸菌をpH5.1まで培養した培養液を混合することにより、比較例1および比較例2の比較製品よりも発酵乳の保存時のビフィドバクテリウム属細菌の生菌数および生残率が高く、更に、酸度やpHの変化も少ないことが分かった。 The product of the present invention of Example 1 is a product of Comparative Example 1 and Comparative Example 2 by mixing a culture solution in which a bacterium belonging to the genus Bifidobacterium is cultured to a pH of 4.4 and a culture solution in which a lactic acid bacterium is cultured to a pH of 5.1. It was found that the viable count and survival rate of Bifidobacterium spp. During storage of fermented milk were higher than those of the comparative product, and that the acidity and pH were also less changed.

実 施 例 2
発酵乳の調製:
14%脱脂粉乳培地にホエーペプチド(LE80GF−US、日本新薬(株)製)および甜茶エキス(YTX−13、(株)ヤクルトマテリアル製)を、それぞれ0.06%および0.2%添加し、溶解させ、120℃で3.5秒間加熱殺菌して培養培地cを調製した。この培地にビフィドバクテリウム・ビフィダム YIT10347のスターター(スターターの生菌数:5.3×10cfu/ml)を4%接種して37℃でpHが4.6(酸度は13)となるまで大気雰囲気下で静置培養を行い、培養液(c)を300g得た。
Example 2
Preparation of fermented milk:
Whey peptide (LE80GF-US, manufactured by Nippon Shinyaku Co., Ltd.) and sweet tea extract (YTX-13, manufactured by Yakult Materials Co., Ltd.) were added to a 14% skim milk powder medium at 0.06% and 0.2%, respectively. The culture medium c was prepared by dissolving and sterilizing by heating at 120 ° C. for 3.5 seconds. This medium is inoculated with 4% of a starter of Bifidobacterium Bifidum YIT10347 (live cell count of starter: 5.3 × 10 8 cfu / ml), and the pH becomes 4.6 (acidity 13) at 37 ° C. The cells were statically cultured in an air atmosphere until 300 g of the culture solution (c) was obtained.

実施例1と同様にして培養液(b)を230g得た。 230 g of the culture solution (b) was obtained in the same manner as in Example 1.

培養液(c)300gおよび培養液(b)230gを各々15MPaで均質化して混合し、混合液を得た(pH4.8)。この混合液に、砂糖8%、スクラロース0.003%、カルボキシメチルセルロースナトリウム0.9%、ジェランガム0.05%を含有するシロップ水溶液468gおよびヨーグルト香料2gを混合し、発酵乳1000gを得た。これをガラス製の試験管にブチルゴム栓で密栓して嫌気充填し、本発明製品とした。 300 g of the culture solution (c) and 230 g of the culture solution (b) were homogenized at 15 MPa and mixed to obtain a mixed solution (pH 4.8). This mixed solution was mixed with 468 g of an aqueous syrup solution containing 8% sugar, 0.003% sucralose, 0.9% sodium carboxymethyl cellulose and 0.05% gellan gum and 2 g of yogurt fragrance to obtain 1000 g of fermented milk. This was sealed in a glass test tube with a butyl rubber stopper and anaerobically filled to obtain the product of the present invention.

実 施 例 3
発酵乳の調製:
実施例2において、培養培地cに添加するホエーペプチドの量を0.12%にする以外は、同様にして培養液(c)を得た。この培養液のpHは4.6で酸度は13であった。
Example 3
Preparation of fermented milk:
In Example 2, a culture solution (c) was obtained in the same manner except that the amount of whey peptide added to the culture medium c was 0.12%. The pH of this culture was 4.6 and the acidity was 13.

実施例2と同様にして本発明製品とした。 The product of the present invention was obtained in the same manner as in Example 2.

実 施 例 4
発酵乳の調製:
実施例2において、培養培地cに添加するホエーペプチドの量を0.18%にする以外は、同様にして培養液(c)を得た。この培養液のpHは4.6で酸度は13であった。
Example 4
Preparation of fermented milk:
In Example 2, a culture solution (c) was obtained in the same manner except that the amount of whey peptide added to the culture medium c was 0.18%. The pH of this culture was 4.6 and the acidity was 13.

実施例2と同様にして本発明製品とした。 The product of the present invention was obtained in the same manner as in Example 2.

比 較 例 3
発酵乳の調製:
実施例2において、培養培地cに添加するホエーペプチドの量を0.12%にする以外は、同様にして培養培地を調製した。この培地にビフィドバクテリウム・ビフィダム YIT10347のスターター(スターターの生菌数:5.3×10cfu/ml)を4%接種して37℃でpHが4.8(酸度は11)となるまで大気雰囲気下で静置培養を行い、培養液(c’)を300g得た。
Comparison example 3
Preparation of fermented milk:
In Example 2, the culture medium was prepared in the same manner except that the amount of whey peptide added to the culture medium c was 0.12%. This medium is inoculated with 4% of a starter of Bifidobacterium Bifidum YIT10347 (live cell count of starter: 5.3 × 10 8 cfu / ml), and the pH becomes 4.8 (acidity 11) at 37 ° C. The cells were statically cultured in an air atmosphere until 300 g of a culture solution (c') was obtained.

培養液(c’)および培養液(b)の全量を各々15MPaで均質化して混合し(pH5.0)、更に乳酸にてpHを4.8に調整して混合液を得た。この混合液に、実施例2と同様のシロップ水溶液468gおよびヨーグルト香料2gを混合し、発酵乳1000gを得た。これをガラス製の試験管にブチルゴム栓で密栓して嫌気充填し比較製品とした。 The total amount of the culture solution (c') and the culture solution (b) was homogenized at 15 MPa and mixed (pH 5.0), and the pH was further adjusted to 4.8 with lactic acid to obtain a mixed solution. This mixed solution was mixed with 468 g of the same syrup aqueous solution and 2 g of yogurt flavor as in Example 2 to obtain 1000 g of fermented milk. This was sealed in a glass test tube with a butyl rubber stopper and anaerobically filled to make a comparative product.

試 験 例 2
保存試験:
試験例1と同様にして、実施例2〜4の本発明製品および比較例3の比較製品について、製造時および10℃保存時の製品の生菌数、生残率を測定または算出し、表2に示す。
Trial example 2
Preservation test:
In the same manner as in Test Example 1, for the products of the present invention of Examples 2 to 4 and the comparative products of Comparative Example 3, the viable cell count and survival rate of the products at the time of manufacture and storage at 10 ° C. were measured or calculated, and the table was obtained. Shown in 2.

Figure 0006978958
Figure 0006978958

実施例2〜4の本発明製品は、比較例3の比較製品よりも発酵乳の保存時のビフィドバクテリウム属細菌の生菌数および生残率が高いことが分かる。 It can be seen that the products of the present invention of Examples 2 to 4 have a higher viable count and survival rate of Bifidobacterium spp. During storage of fermented milk than the comparative products of Comparative Example 3.

本発明の発酵乳の製造方法は、健康の増進に有用なビフィドバクテリウム属細菌を含有する発酵乳の製造に利用することができる。

以 上
The method for producing fermented milk of the present invention can be used for producing fermented milk containing Bifidobacterium spp., Which is useful for promoting health.

that's all

Claims (12)

乳を主成分とする培地Aにビフィドバクテリウム属細菌を接種し、培養して得られるpH4.3〜4.7の培養液(A)と、
乳を主成分とする培地Bに乳酸菌を接種し、培養して得られるpH4.8〜5.4の培養液(B)とを、
混合することを特徴とする発酵乳の製造方法。
Bifidobacterium genus bacteria are inoculated into medium A containing milk as a main component and cultured to obtain a culture medium (A) having a pH of 4.3 to 4.7.
A culture medium (B) having a pH of 4.8 to 5.4 obtained by inoculating a medium B containing milk as a main component with lactic acid bacteria and culturing the medium B is used.
A method for producing fermented milk, which comprises mixing.
ビフィドバクテリウム属細菌がビフィドバクテリウム・ブレーベ、ビフィドバクテリウム・ビフィダム、ビフィドバクテリウム・シュードカテヌラータム、ビフィドバクテリウム・アニマリスおよびビフィドバクテリウム・ラクチスからなる群から選ばれる1種以上である請求項1記載の発酵乳の製造方法。 Bifidobacterium spp. Are selected from the group consisting of Bifidobacterium breve, Bifidobacterium bifidam, Bifidobacterium pseudocatenulatum, Bifidobacterium animalis and Bifidobacterium lactis. The method for producing fermented milk according to claim 1, wherein the fermented milk is one or more. 培地Bに接種される乳酸菌がストレプトコッカス・サーモフィルス、ラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリクス、ラクトコッカス・ラクチスおよびラクトコッカス・クレモリスからなる群から選ばれる1種以上である請求項1又は2記載の発酵乳の製造方法。 2. The method for producing fermented milk according to the description. 培養液(A)が培地Aにビフィドバクテリウム属細菌と共に乳酸菌を接種し、培養して得られるものである請求項1〜3の何れか1項に記載の発酵乳の製造方法。 The method for producing fermented milk according to any one of claims 1 to 3, wherein the culture solution (A) is obtained by inoculating medium A with lactic acid bacteria together with bifidobacteria and culturing the medium A. 培地Aに接種される乳酸菌がラクトコッカス・ラクチスである請求項4記載の発酵乳の製造方法。 The method for producing fermented milk according to claim 4, wherein the lactic acid bacterium inoculated into the medium A is Lactococcus lactis. 培養液(A)と、培養液(B)とを混合後の発酵乳のpHが4.5〜5.2である請求項1〜5の何れか1項に記載の発酵乳の製造方法。 The method for producing fermented milk according to any one of claims 1 to 5, wherein the pH of the fermented milk after mixing the culture solution (A) and the culture solution (B) is 4.5 to 5.2. 10℃で21日間保存した場合のビフィドバクテリウム属細菌の生菌数が1×10個/ml以上である請求項1〜6の何れか1項に記載の発酵乳の製造方法。 The method for producing fermented milk according to any one of claims 1 to 6, wherein the viable number of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 1 × 10 9 cells / ml or more. ビフィドバクテリウム属細菌の初発の生菌数が1.2×10〜2.3×10個/mlである請求項1〜7の何れか1項に記載の発酵乳の製造方法。 The method for producing fermented milk according to any one of claims 1 to 7, wherein the initial viable number of Bifidobacterium spp. Is 1.2 × 10 9 to 2.3 × 10 9 cells / ml. 10℃で21日間保存した場合のビフィドバクテリウム属細菌の生残率が50%以上である請求項1〜8の何れか1項に記載の発酵乳の製造方法。 The method for producing fermented milk according to any one of claims 1 to 8, wherein the survival rate of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 50% or more. 請求項1〜9の何れか1項に記載の発酵乳の製造方法で製造される発酵乳であって、
10℃で21日間保存した場合のビフィドバクテリウム属細菌の生菌数が1×10個/ml以上であることを特徴とする発酵乳。
A fermented milk produced by the method for producing a fermented milk according to any one of claims 1 to 9.
Fermented milk characterized in that the viable number of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 1 × 10 9 cells / ml or more.
ビフィドバクテリウム属細菌の初発の生菌数が1.2×10〜2.3×10個/mlである請求項10記載の発酵乳。 The fermented milk according to claim 10, wherein the initial viable number of Bifidobacterium spp. Is 1.2 × 10 9 to 2.3 × 10 9 cells / ml. 10℃で21日間保存した場合のビフィドバクテリウム属細菌の生残率が50%以上である請求項10又は11記載の発酵乳。 The fermented milk according to claim 10 or 11, wherein the survival rate of Bifidobacterium spp. When stored at 10 ° C. for 21 days is 50% or more.
JP2018024035A 2018-02-14 2018-02-14 Method for producing fermented milk containing bifidobacteria and lactic acid bacteria Active JP6978958B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018024035A JP6978958B2 (en) 2018-02-14 2018-02-14 Method for producing fermented milk containing bifidobacteria and lactic acid bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018024035A JP6978958B2 (en) 2018-02-14 2018-02-14 Method for producing fermented milk containing bifidobacteria and lactic acid bacteria

Publications (2)

Publication Number Publication Date
JP2019136002A JP2019136002A (en) 2019-08-22
JP6978958B2 true JP6978958B2 (en) 2021-12-08

Family

ID=67692418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018024035A Active JP6978958B2 (en) 2018-02-14 2018-02-14 Method for producing fermented milk containing bifidobacteria and lactic acid bacteria

Country Status (1)

Country Link
JP (1) JP6978958B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7523898B2 (en) * 2019-09-30 2024-07-29 キリンホールディングス株式会社 A method for producing fermented milk in which the decrease in the content of functional peptides during the fermentation process is suppressed

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5414585A (en) * 1977-07-01 1979-02-02 Yakult Honsha Kk Production of milk culturing substance containing bifidobacterium bacillus and slow acid producing lactobacillus
JPH0687732B2 (en) * 1987-02-25 1994-11-09 カルピス食品工業株式会社 Method for producing fermented milk containing bifidobacteria
JP5829483B2 (en) * 2011-10-27 2015-12-09 株式会社ヤクルト本社 Method for producing bifidobacteria fermented milk
JP6709683B2 (en) * 2016-05-30 2020-06-17 森永乳業株式会社 Method for producing concentrated fermented milk

Also Published As

Publication number Publication date
JP2019136002A (en) 2019-08-22

Similar Documents

Publication Publication Date Title
JP5518178B2 (en) Novel lactic acid bacteria belonging to Lactobacillus plantarum and their use
KR102028744B1 (en) Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof
US20100015285A1 (en) Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature
EP1972208A1 (en) Composition for improving intestinal microflora
WO2021256476A1 (en) Method for improving resistance of lactic acid bacteria to gastric juices/bile
TW201225855A (en) Fermented food and method for producing same
CN108004167A (en) Streptococcus thermophilus JMCC0019, its isolation and purification method and the application of one plant of extracellular polysaccharide
WO2003040350A1 (en) Bacterium of the genus bifidobacterium and fermented foods using the same
KR101707551B1 (en) Method for Preparing Chocolates Containing Viable Preparations of Lactic Acid Bacteria
CN115281247A (en) Lactobacillus fermentum normal-temperature yogurt and preparation method thereof
JP6978958B2 (en) Method for producing fermented milk containing bifidobacteria and lactic acid bacteria
JP5268916B2 (en) Acid lactic acid bacteria beverage, method for producing acid lactic acid bacteria beverage, and method for improving survival of bifidobacteria
JP2001112437A (en) Production of food and drink containing bacteria of genus bifidobacterium
JP7506963B2 (en) Lactic acid bacteria medium
JP3399919B2 (en) Fermented milk food
TW201642750A (en) Method for producing fermented milk food
JP2013090604A (en) Method for producing bifidobacterium fermented milk
JP7535493B2 (en) Method for producing culture of lactic acid bacteria and/or bifidobacterium
JP7249189B2 (en) Low-fat fermented food and method for producing the same
JP2021164435A (en) Bifidobacteria proliferation promotor
JP7035283B1 (en) A novel lactic acid bacterium strain and a composition containing the novel lactic acid bacterium strain.
JP5980785B2 (en) New bifidobacteria and their use
JP2020137471A (en) Fermented milk
WO2021095476A1 (en) Method for producing fermented milk containing oligosaccharides
JP2001120180A (en) Soybean milk fermented food containing bifidobacterium

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200826

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211110

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211112

R151 Written notification of patent or utility model registration

Ref document number: 6978958

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151